Viemed Healthcare (VMD) Total Non-Current Liabilities (2018 - 2026)
Viemed Healthcare's (VMD) quarterly Total Non-Current Liabilities came in at $10.9 million in Q1 2026, up 85.85% YoY from $5.8 million in Q1 2025, and down 25.51% on a QoQ basis from $14.6 million in Q4 2025.
Viemed Healthcare (VMD) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Viemed Healthcare (VMD) has 9 years of Total Non-Current Liabilities data on file, last reported at $10.9 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 85.85% year-over-year to $10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (up 85.85% YoY) and the FY2025 annual result came in at $14.6 million, up 126.28% from the prior year.
- Total Non-Current Liabilities fell to $10.9 million in Q1 2026, from $14.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $22.7 million in Q3 2025 to a low of $1.1 million in Q4 2022.
- A 5-year average of $8.3 million and a median of $6.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities plunged 79.59% — and 2023, when it jumped 715.81%.
- Tracing VMD's Total Non-Current Liabilities over 5 years: stood at $1.1 million in 2022, then jumped by 715.81% to $8.9 million in 2023, then retreated by 27.42% to $6.4 million in 2024, then surged by 126.28% to $14.6 million in 2025, then declined by 25.51% to $10.9 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $10.9 million (Q1 2026), $14.6 million (Q4 2025), and $22.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Viemed Healthcare | 328.34 Mn | 317.66 Mn | 45.05 Mn | 10.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.37 Mn |
| Mar 31, 2026 | 10.86 Mn |
| Dec 31, 2025 | 14.58 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 5.84 Mn |
| Dec 31, 2024 | 6.44 Mn |
| Sep 30, 2024 | 6.29 Mn |
| Jun 30, 2024 | 11.29 Mn |
| Mar 31, 2024 | 8.49 Mn |
| Dec 31, 2023 | 8.88 Mn |
| Sep 30, 2023 | 9.03 Mn |
| Jun 30, 2023 | 13.04 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 4.95 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Mar 31, 2022 | 5.23 Mn |
| Dec 31, 2021 | 5.33 Mn |
| Sep 30, 2021 | 5.91 Mn |